FDA Approved: * May 1, 2023
Pharm Company: * NOVITIUM PHARMA
Category: Anticonvulsant

Mesuximide (or methsuximide, methosuximide) is a succinimide anticonvulsant medication. It is sold as a racemate by Pfizer under the tradenames Petinutin (Switzerland)[1] and Celontin (United States).[2] The therapeutic efficacy of methosuximide is largely due to its pharmacologically active metabolite, N-desmethylmethosuximide, which has a longer half-life and attains much higher plasma levels than its parent.[3] Medical use is indicated for... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Methsuximide 300 mg Oral Capsule
NDC: 70954-228
Ani Pharmaceuticals, Inc.

Related Brands

Drugs with the same active ingredients